MeritCare Broadway Health Center Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
1994
NCT00960245
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1994

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

nadolol (corgard) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chest Pain (Phase 1)

Headache (Phase 1)

Hypertension (Phase 1)

Migraine Disorders (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1